GalenusRx

GalenusRx, founded in 2023 by a group of internationally recognized healthcare leaders, is revolutionizing medication safety with the power of precision. The company's proprietary platform, APPRAISE, analyzes drug-drug, multi-drug, drug-gene, and drug-disease interactions to deliver unique and comprehensive risk assessments personalized down to the DNA level. Through its Lifesaving Insights™ consulting service, precision clinical pharmacists provide tailored recommendations for safer and more effective medication treatment plans. Together, these solutions directly address the risks of polypharmacy and adverse drug events – a leading cause of death in the United States. GalenusRx’s advanced data analytics also enhance the quality, safety, and efficiency of virtual clinical trials, enabling biosimulation based on real patient data without exposing patients to risk. From consumers to healthcare providers, insurance companies, and pharmaceutical firms, GalenusRx’s technology drives better health outcomes and reduced total healthcare costs.